Unlocking the power of gene expression: Molecular classification of brain tumors

Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes.

Mayo Clinic study finds no link between anesthesia exposure, mild cognitive impairment

A Mayo Clinic study of people who received anesthesia for surgery after age 40 found no association between the anesthesia and the development of mild cognitive impairment later in life.

Subarachnoid hemorrhage from ruptured brain aneurysm

Giuseppe Lanzino, M.D., and Alejandro A. Rabinstein, M.D., discuss treatment of patients with subarachnoid hemorrhages that result from ruptured brain aneurysms. This condition, one of the most complex acute conditions encountered in medicine, ...

Grand Rounds: Cognitive Decline in the Elderly and the Role of Cognitive Reserve

Prashanthi Vemuri, Ph.D., presents Cognitive Decline in the Elderly and the Role of Cognitive Reserve.

Is it dementia, or just normal aging? New tool may help triage

Ronald Petersen, M.D., Ph.D., discusses a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia.

Mayo Clinic study of thousands of brains reveals tau as driver of Alzheimer's disease

By examining more than 3,600 postmortem brains, researchers at Mayo Clinic have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease.

Advancing the knowledge of ALS and FTD

Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.

Grand Rounds— Identifying and Translating Biomarkers for Neurodegenerative Diseases: Experience With Sphingolipids

Michelle M. Mielke, Ph.D., presents Identifying and Translating Biomarkers for Neurodegenerative Diseases: Experience With Sphingolipids.

Advancements in multiple sclerosis research hold promise for patients

Dean M. Wingerchuk, M.D., neurologist at Mayo Clinic's campus in Arizona, explains how the future holds promise for multiple sclerosis research.